Top news of the week: 31.05.2022.
Startups
First life sciences, now clean energy: Baker eyes next big industry for Mass.
Governor Charlie Baker and legislative leaders want to pump up the state’s clean energy industry, but they differ on how to do it.
GSK wagers $2.1B on Affinivax and its next-generation pneumonia vaccine
The deal is the second acquisition for GSK since April and gives the company access to an experimental shot that’s meant to surpass new products from Pfizer and Merck & Co.
Biotech’s Dulcius Ex Asperis: The Way Through This Downturn
The biotech sector is experiencing the most severe downturn of at least the last 20 years. There have been many other downturns in the more recent past, but this one is different. Here ...
Good Day BIO: Bipartisan bill would address PBMs
A bipartisan bill introduced this week would address PBM transparency and business practices, and new data shows how PBM formulary exclusion lists continue to grow. Plus, details on a new ...
Stablix Appoints Eddine Saiah Chief Scientific Officer and Expands Leadership Team
Stablix, Inc., a biopharmaceutical company pioneering targeted protein stabilization (TPS) as a novel therapeutic modality, today announced that Eddin
3 cancer drug studies to watch at next month’s ASCO meeting
Detailed results from important studies of AstraZeneca’s breast cancer drug Enhertu, Gilead’s Trodelvy and Roche’s TIGIT blocker are among the most anticipated late-breaking data set to be ...
New Pivotal Data Demonstrate Clinical Benefit of Genentech’s Glofitamab, a Potential First-in-Class Bispecific Antibody for People with Aggressive Lymphoma
Discover the latest news about our company, our products, our policies, and our people.
Advent Life Sciences Announces Growth of Investment Team with Three Senior Appointments
/PRNewswire/ -- Advent Life Sciences, a leading transatlantic venture and growth investor focused on building innovative life science companies in the UK,...